Exor delivers 9% Nav Per Share growth in 2024 - Launch of a €1 billion Share Buyback Program with Tender Offer at up to 10% premium
- NAV reached €38.2 billion at 31 December 2024, with NAV per share increasing by 9%
- Strong cash flow generation with dividends received from companies and asset disposals amounting to €1.5 billion in 2024. Active and disciplined capital allocation with increased exposure to Healthcare
- Ordinary dividend to be distributed of approximately €100 million, subject to AGM approval
- Launch of a new €1 billion share buyback program in the form of a Tender Offer starting 27 March 2025 at
Exor N.V. publishes its 2025 Corporate Calendar
EXOR N.V. announced today the following Corporate Calendar for 2025:
• 26 March 2025: Board of Directors Meeting for the approval of the Company’s 2024 Annual Report
• 22 May 2025: Annual General Meeting of Shareholders for the adoption of the Company’s 2024 Financial Statements
• 17 September 2025: Board of Directors Meeting for the approval of the Company’s 2025 Half-Year Financial Report
Exor announces evolution of its early-stage venture activities
Exor announces that Noam Ohana, who has led early-stage investments at Exor, has decided to launch his own fund.
Alongside his new venture, Noam Ohana will continue to manage Exor Ventures’ €640 million portfolio for the benefit of Exor as an independent fund manager.
Exor extends its gratitude to Noam for the years of collaboration and wishes him full success in this next stage of his life as an entrepreneur and investor.